UK weighs carrier status policy in neonatal screening
This article was originally published in Clinica
Executive Summary
The introduction of two neonatal screening programmes - sickle cell disorders (SCDs) and cystic fibrosis (CF) - in England has led the UK's Department to Health to launch an investigation into how carrier status should be handled in these and similar screening programmes, with potential implications for the choice of technologies used.